Ultesan contains the active substance irbesartan which belongs to a group of medicines known as angiotensin II receptors antagonists. Angiotensin II is a substance produced in the body which binds to receptors in blood vessels causing them to tighten. This results in an increase in blood pressure. Ultesan prevents the binding of angiotensin II to these receptors, causing the blood vessels to relax and the blood pressure to lower. Ultesan slows the decrease of kidney function in patients with high blood pressure and type 2 diabetes.
Ultesan is used in adult patients:
• to treat high blood pressure (essential hypertension);
• to protect the kidney in patients with high blood pressure, type 2 diabetes and laboratory evidence of impaired kidney function.